|
Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Ciruelos EM, Munoz M, Bermejo B, Margeli M, Csoszi T, Anton A, Turner N, Casas MI, Morales S, Alba E, Calvo L, de la Haba-Rodriguez J, Ramos M, Murillo L, Santaballa A, Alonso-Romero JL, Sanchez-Rovira P, Corsaro M, Huang X, Thallinger C, Kahan Z, Gil-Gil M. Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study. Eur J Cancer. 2022 Jun;168:12-24. doi: 10.1016/j.ejca.2022.03.006. Epub 2022 Apr 13. PubMed PMID: 35429901.
AÑO: 2022; IF: 8.4
|
35429901
|
Garcia-Saenz JA, Martinez-Janez N, Cubedo R, Jerez Y, Lahuerta A, Gonzalez-Santiago S, Ferrer N, Ramos M, Alonso-Romero JL, Anton A, Carrasco E, Chen J, Neuwirth R, Galinsky K, Vincent S, Leonard EJ, Slamon D. Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor. Clin Cancer Res. 2022 Mar 15;28(6):1107-1116. doi: 10.1158/1078-0432.CCR-21-2652. PubMed PMID: 34980598; PubMed Central PMCID: PMC9365359.
AÑO: 2022; IF: 11.5
|
|
Sanchez Martinez DA, Salas-Lucia F, Jiang H, Ruiz-Carreno P, Alonso Romero JL. Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact. BMC Health Serv Res. 2022 Jul 26;22(1):948. doi: 10.1186/s12913-022-08222-9. PubMed PMID: 35883128; PubMed Central PMCID: PMC9316356.
AÑO: 2022; IF: 2.908
|
|
de la Cruz-Merino L, Gion M, Cruz-Jurado J, Quiroga V, Andres R, Moreno F, Alonso-Romero JL, Ramos M, Holgado E, Cortes J, Lopez-Miranda E, Henao-Carrasco F, Palazon-Carrion N, Rodriguez LM, Ceballos I, Casas M, Benito S, Chiesa M, Bezares S, Caballero R, Jimenez-Cortegana C, Sanchez-Margalet V, Rojo F. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study. Cancers (Basel). 2021 Oct 29;13(21):5432. doi: 10.3390/cancers13215432. PubMed PMID: 34771596; PubMed Central PMCID: PMC8582406.
AÑO: 2021; IF: 6.575
|
|
Sanchez Martinez DA, Canadilla-Ferreira M, Henarejos PS, Alonso Romero JL. Analysis of adolescent oncology cases from 2008 through 2018 in a tertiary-level hospital: an opportunity for improvement. Future Oncol. 2021 Apr;17(12):1545-1551. doi: 10.2217/fon-2020-0475. Epub 2021 Feb 25. PubMed PMID: 33626935.
AÑO: 2021; IF: 3.674
|